Healthtech Startups

Dr. Mohan's is Asia's largest healthcare network specializing in diabetes treatment and complications management. The organization operates comprehensive diabetes care services across multiple facilities with over 33 years of clinical and research experience.

1 investor

Dropprint Genomics develops software for analyzing individual cell activity in genomic data, serving researchers in immunology and drug discovery. The company reduces the cost and computational complexity of single-cell sequencing and maintains a database of over 1 million immune cells to support target identification using machine learning models.

1 investor

Dropstat offers a managed staff scheduling service backed by purpose-built software for skilled nursing and healthcare facilities. It coordinates shift coverage, reduces overtime and agency labor costs, and provides centralized visibility for facility leaders.

1 investor

ViuHealth provides 24/7 access to mental health care through a team of licensed psychologists, psychiatrists, and other mental health professionals. The platform offers tools to support patients in managing their mental health conditions.

1 investor

DryLabz builds diagnostics technology aimed at making better use of healthcare data to support clinical decision-making. The company targets healthcare stakeholders including patients, clinicians, and insurers to enable faster, more personalized care.

1 investor

DST develops allergy and food intolerance diagnostic products for medical laboratories and healthcare professionals, including laboratory tests and point-of-care testing systems. The company focuses on tailored diagnostic solutions for different geographic regions.

1 investor

dubidoc develops practice management and appointment scheduling software for ambulatory healthcare facilities in Germany. The modular platform integrates with existing systems to support networked healthcare delivery and reduce administrative burden on medical staff.

1 investor

Dunatura offers pre-portioned daily supplement packs designed to simplify supplement routines for fitness enthusiasts and muscle builders. The product provides pre-measured dosages in convenient daily packets.

1 investor

Duo Oncology is a clinical-stage company developing tumor-activated prodrug combinations intended to replace toxic multi-agent chemotherapy with single medicines that concentrate activity in tumors. Its lead candidate, DUO-207, combines gemcitabine and paclitaxel into a single-infusion prodrug positioned as a chemotherapy backbone for use with KRAS inhibitors in solid tumors such as pancreatic, lung, and breast cancer.

1 investor

Duroflex manufactures and sells mattresses, bed linen, and sleep-related furniture designed to improve sleep quality. The company operates through manufacturing facilities across 8 locations in India and sells via experience centers and online channels.

1 investor

Dusmit develops air purification solutions for food production, post-harvest operations, indoor growing facilities, and medical environments. The company specializes in analyzing and identifying air contaminants to create tailored systems that improve crop quality, extend shelf life, and maintain sterile conditions.

1 investor

DVLP is a biotechnology company developing vaccine platforms using artificial intelligence, synthetic biology, and immunology. The company appears to focus on next-generation vaccine development beyond mRNA technologies.

1 investor

DxLab develops multiplex molecular diagnostic technology (LAMP+) for rapid, low-cost point-of-care infectious disease testing, including its DxHub portable testing platform, DxTests, and ready-to-use LAMP master mixes. Founded by MIT and Harvard graduates, it serves public health applications such as Mpox and antimicrobial resistance detection.

1 investor

Dynamics VR develops VR therapy software and hardware packages for clinical settings. The company offers modular VR systems bundled with therapeutic software and training, designed for medical clinics and therapists.

1 investor

Dynavax is a commercial-stage biopharmaceutical company that develops and commercializes vaccines against infectious diseases using its adjuvant technology. Its products target immunization and infectious disease prevention.

1 investor

DYNTL builds tech-enabled onsite, nearsite, and virtual dental clinics for institutional partners such as universities, employers, union and Taft-Hartley funds, health systems, and dental plans. It provides turnkey dental service platforms, including build-out, staffing, and financial partnership, aimed at integrating oral care into broader population health strategies.

1 investor

DYSIS Medical develops computer-aided imaging technology integrated with colposcopes to help healthcare professionals detect cervical lesions more efficiently. The company manufactures and markets medical devices for cervical cancer screening and diagnosis.

1 investor

EADERM develops pharmaceuticals and therapeutics for hair loss and skin disorders based on tissue stem cell aging and regeneration control technology. The company targets treatment and prevention of alopecia and age-related skin conditions through innovative approaches centered on cellular mechanisms rather than symptomatic relief.

1 investor

Eaglenos develops smart healthcare technologies, focusing on precision testing and personalized health management.

1 investor

Eaglet Eye develops corneal and scleral profiling technology for ophthalmological diagnostics. The company produces advanced topography systems used in eye care and clinical applications.

1 investor

Earflo develops a non-invasive home treatment device for negative middle ear pressure in children, addressing a common pediatric condition that affects millions of children annually. The product aims to help families avoid ear surgery while providing evidence-based symptom relief and long-term health benefits.

1 investor

Earli Point Health is a company that offers the EarliPoint System, an FDA-cleared medical device designed to aid clinicians in diagnosing and assessing autism spectrum disorder in children using objective measurement of looking behavior during video presentations, complementing traditional ABA therapy assessments.

1 investor

Acrew Capital is a venture capital firm that invests across multiple sectors including fintech, AI, healthcare, data & security, and community-activated companies.

1 investor

Early develops a home urinalysis system that pairs a clinical-grade electrochemical reader with disposable urine tests to screen for markers of serious conditions such as urinary tract cancers, diabetes, kidney disease, and heart disease risk, plus wellness markers, delivering results to an app in under five minutes. The consumer product is aimed at at-home early disease detection and is planned to launch in Spring 2027.

1 investor